In this report, according to this study, over the next five years the Aurora Kinase Amarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Aurora Kinase Abusiness.
Aurora Kinase A market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Aurora Kinase A for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global Aurora Kinase A market competition by top manufacturers/players, with Aurora Kinase A sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
AbbVie Inc.
Amgen Inc.
Astex Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc.
Merck & Co., Inc.
Millennium Pharmaceuticals, Inc.
Sanofi
Sareum Holdings Plc
Sigma-Tau S.p.A.
Taiho Pharmaceutical Co., Ltd.
Vertex Pharmaceuticals Incorporated
Vichem Chemie Research Ltd.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
AMG-900
Danusertib
ENMD-2076
Ilorasertib
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Aurora Kinase A for each application, including
Ovarian Cancer
Anaplastic Large Cell Lymphoma
Brain Tumor
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Aurora Kinase A Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 AMG-900
2.1.2 Danusertib
2.1.3 ENMD-2076
2.1.4 Ilorasertib
2.1.5 Others
2.2 Overall Market Performance(Value)
2.2.1 AMG-900
2.2.2 Danusertib
2.2.3 ENMD-2076
2.2.4 Ilorasertib
2.2.5 Others
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Ovarian Cancer
3.1.2 Anaplastic Large Cell Lymphoma
3.1.3 Brain Tumor
3.1.4 Others
4 Manufacturers Profiles/Analysis
4.1 AbbVie Inc.
4.1.1 AbbVie Inc. Profiles
4.1.2 AbbVie Inc. Product Information
4.1.3 AbbVie Inc. Aurora Kinase A Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 AbbVie Inc. SWOT Analysis
4.2 Amgen Inc.
4.2.1 Amgen Inc. Profiles
4.2.2 Amgen Inc. Product Information
4.2.3 Amgen Inc. Aurora Kinase ASales, Sales Value (Million USD), Price and Gross Profit
4.2.4 Amgen Inc. SWOT Analysis
4.3 Astex Pharmaceuticals, Inc.
4.3.1 Astex Pharmaceuticals, Inc. Profiles
4.3.2 Astex Pharmaceuticals, Inc. Product Information
4.3.3 Astex Pharmaceuticals, Inc. Aurora Kinase ASales, Sales Value (Million USD), Price and Gross Profit
4.3.4 Astex Pharmaceuticals, Inc. SWOT Analysis
4.4 CASI Pharmaceuticals Inc.
4.4.1 CASI Pharmaceuticals Inc. Profiles
4.4.2 CASI Pharmaceuticals Inc. Product Information
4.4.3 CASI Pharmaceuticals Inc. Aurora Kinase ASales, Sales Value (Million USD), Price and Gross Profit
4.4.4 CASI Pharmaceuticals Inc. SWOT Analysis
4.5 Merck & Co., Inc.
4.5.1 Merck & Co., Inc. Profiles
4.5.2 Merck & Co., Inc. Product Information
4.5.3 Merck & Co., Inc. Aurora Kinase ASales, Sales Value (Million USD), Price and Gross Profit
4.5.4 Merck & Co., Inc. SWOT Analysis
4.6 Millennium Pharmaceuticals, Inc.
4.6.1 Millennium Pharmaceuticals, Inc. Profiles
4.6.2 Millennium Pharmaceuticals, Inc. Product Information
4.6.3 Millennium Pharmaceuticals, Inc. Aurora Kinase ASales, Sales Value (Million USD), Price and Gross Profit
4.6.4 Millennium Pharmaceuticals, Inc. SWOT Analysis
4.7 Sanofi
4.7.1 Sanofi Profiles
4.7.2 Sanofi Product Information
4.7.3 Sanofi Aurora Kinase ASales, Sales Value (Million USD), Price and Gross Profit
4.7.4 Sanofi SWOT Analysis
4.8 Sareum Holdings Plc
4.8.1 Sareum Holdings Plc Profiles
4.8.2 Sareum Holdings Plc Product Information
4.8.3 Sareum Holdings Plc Aurora Kinase ASales, Sales Value (Million USD), Price and Gross Profit
4.8.4 Sareum Holdings Plc SWOT Analysis
4.9 Sigma-Tau S.p.A.
4.9.1 Sigma-Tau S.p.A. Profiles
4.9.2 Sigma-Tau S.p.A. Product Information
4.9.3 Sigma-Tau S.p.A. Aurora Kinase ASales, Sales Value (Million USD), Price and Gross Profit
4.9.4 Sigma-Tau S.p.A. SWOT Analysis
4.10 Taiho Pharmaceutical Co., Ltd.
4.10.1 Taiho Pharmaceutical Co., Ltd. Profiles
4.10.2 Taiho Pharmaceutical Co., Ltd. Product Information
4.10.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase ASales, Sales Value (Million USD), Price and Gross Profit
4.10.4 Taiho Pharmaceutical Co., Ltd. SWOT Analysis
4.11 Vertex Pharmaceuticals Incorporated
4.12 Vichem Chemie Research Ltd.
5 Market Performance for Manufacturers
5.1 Global Aurora Kinase A Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global Aurora Kinase A Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global Aurora Kinase A Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global Aurora Kinase A Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Aurora Kinase A Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China Aurora Kinase A Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China Aurora Kinase A Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China Aurora Kinase A Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Aurora Kinase A Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA Aurora Kinase A Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA Aurora Kinase A Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA Aurora Kinase A Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Aurora Kinase A Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe Aurora Kinase A Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe Aurora Kinase A Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe Aurora Kinase A Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Aurora Kinase A Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan Aurora Kinase A Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan Aurora Kinase A Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan Aurora Kinase A Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Aurora Kinase A Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea Aurora Kinase A Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea Aurora Kinase A Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea Aurora Kinase A Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Aurora Kinase A Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India Aurora Kinase A Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India Aurora Kinase A Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India Aurora Kinase A Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Aurora Kinase A Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia Aurora Kinase A Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia Aurora Kinase A Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia Aurora Kinase A Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Aurora Kinase A Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America Aurora Kinase A Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America Aurora Kinase A Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America Aurora Kinase A Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global Aurora Kinase A Market Assessment by Regions (2014-2020)
7.1 Global Aurora Kinase A Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global Aurora Kinase A Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global Aurora Kinase A Price (USD/Unit) by Regions 2014-2020
7.4 Global Aurora Kinase A Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global Aurora Kinase A Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China Aurora Kinase A Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA Aurora Kinase A Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe Aurora Kinase A Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan Aurora Kinase A Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea Aurora Kinase A Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India Aurora Kinase A Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Aurora Kinase A Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Aurora Kinase A Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Ovarian Cancer Industry
11.2 Anaplastic Large Cell Lymphoma Industry
11.3 Brain Tumor Industry
11.4 Others Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global Aurora Kinase A Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global Aurora Kinase A Sales (K Units) and Growth Rate 2021-2026
12.1.3 China Aurora Kinase A Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA Aurora Kinase A Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe Aurora Kinase A Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan Aurora Kinase A Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea Aurora Kinase A Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India Aurora Kinase A Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia Aurora Kinase A Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America Aurora Kinase A Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 AMG-900
12.2.3 Danusertib
12.2.4 ENMD-2076
12.2.5 Ilorasertib
12.2.6 Others
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Ovarian Cancer
12.3.3 Anaplastic Large Cell Lymphoma
12.3.4 Brain Tumor
12.3.5 Others
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Aurora Kinase A Price (USD/Unit) Trend 2021-2026
12.4.2 Global Aurora Kinase A Gross Profit Trend 2021-2026
13 Conclusion